Glynase XL 5 mg Tablets contain Glipizide, a second-generation sulfonylurea used to manage type 2 diabetes mellitus. This extended-release formulation provides long-acting control over blood sugar levels by stimulating insulin secretion from the pancreas and improving insulin sensitivity. It is most effective when combined with proper diet and exercise.

• Extended-release action ensures consistent blood glucose control

• Low-dose option ideal for initial therapy or dose adjustments

• Once-daily dosing enhances convenience and compliance

• Reduces the risk of diabetes-related complications

• Can be used as monotherapy or with other anti-diabetic agents

• Take one tablet daily, preferably 30 minutes before breakfast

• Swallow whole with water; do not crush, chew, or split the tablet

• Take at the same time each day to maintain effectiveness

• Follow your doctor’s dietary and exercise plan alongside medication

• Typical starting dose: 5 mg once daily

• Dose may be increased based on blood glucose response

• Maximum recommended dose: 20 mg/day

• Do not double dose if you miss one; skip and continue as scheduled

• Not suitable for patients with type 1 diabetes or diabetic ketoacidosis

• Use caution in individuals with renal or hepatic impairment

• Avoid alcohol consumption as it increases hypoglycemia risk

• Inform your doctor if you have sulfa drug allergies

• Monitor blood glucose regularly to track effectiveness and avoid hypoglycemia

• Common:

• Hypoglycemia (low blood sugar)

• Dizziness or fatigue

• Less Common/Rare:

• Skin rashes or allergic reactions

• Liver enzyme elevation

• Blood count abnormalities (rare)

• Visual disturbances

•  

• Headache

• Nausea or mild stomach upset